TERM ID="NYU_TERM_1" STRING="Bevacizumab" FREQUENCY=2 START=750 END=761 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="Bevacizumab" FREQUENCY=2 START=968 END=979 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="Clinical relevance" FREQUENCY=1 START=0 END=18 LEMMA="CLINICAL RELEVANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Clinical relevance of monoclonal antibodies" FREQUENCY=1 START=0 END=43 LEMMA="MONOCLONAL ANTIBODY CLINICAL RELEVANCE" LEMMA_FREQUENCY=1 HEAD_TERM="Clinical relevance" HEAD_LEMMA="CLINICAL RELEVANCE"
TERM ID="NYU_TERM_5" STRING="Current strategies" FREQUENCY=1 START=198 END=216 LEMMA="CURRENT STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="EGFR-positive NSCLC" FREQUENCY=1 START=638 END=657 LEMMA="EGFR-POSITIVE NSCLC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Epidermal growth factor receptor (EGFR)-directed monoclonal antibodies" FREQUENCY=1 START=302 END=372 LEMMA="EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-DIRECTED MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Figitumumab" FREQUENCY=1 START=1087 END=1098 LEMMA="FIGITUMUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_9" STRING="IGF-1R" FREQUENCY=1 START=1175 END=1181 LEMMA="INSULIN LIKE GROWTH FACTOR 1 RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="NSCLC" FREQUENCY=3 START=190 END=195 LEMMA="NON SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_11" STRING="NSCLC" FREQUENCY=3 START=1032 END=1037 LEMMA="NON SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_12" STRING="NSCLC" FREQUENCY=3 START=1236 END=1241 LEMMA="NON SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_13" STRING="Targeted therapies" FREQUENCY=1 START=74 END=92 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="angiogenesis" FREQUENCY=2 START=288 END=300 LEMMA="ANGIOGENESI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="angiogenesis" FREQUENCY=2 START=673 END=685 LEMMA="ANGIOGENESI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="cisplatin" FREQUENCY=1 START=528 END=537 LEMMA="CISPLATIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="figitumumab" FREQUENCY=1 START=1367 END=1378 LEMMA="FIGITUMUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="first-line chemotherapy" FREQUENCY=1 START=408 END=431 LEMMA="FIRST-LINE CHEMOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="growth factor receptors" FREQUENCY=1 START=242 END=265 LEMMA="GROWTH FACTOR RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="improved progression-free survival" FREQUENCY=1 START=799 END=833 LEMMA="IMPROVED PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="insulin-like growth factor-1 receptor" FREQUENCY=2 START=1136 END=1173 LEMMA="INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_22" STRING="insulin-like growth factor-1 receptor" FREQUENCY=2 START=1136 END=1173 LEMMA="INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="metastatic NSCLC" FREQUENCY=1 START=1416 END=1432 LEMMA="METASTATIC NSCLC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="monoclonal antibodies" FREQUENCY=2 START=22 END=43 LEMMA="MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_25" STRING="monoclonal antibodies" FREQUENCY=2 START=98 END=119 LEMMA="MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_26" STRING="monoclonal antibody" FREQUENCY=1 START=1104 END=1123 LEMMA="MONOCLONAL ANTIBODY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_27" STRING="non small cell lung cancer" FREQUENCY=1 START=47 END=73 LEMMA="NON SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_28" STRING="non small cell lung cancer Targeted therapies" FREQUENCY=1 START=47 END=92 LEMMA="TARGETED THERAPY NON SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=1 HEAD_TERM="Targeted therapies" HEAD_LEMMA="TARGETED THERAPY"
TERM ID="NYU_TERM_29" STRING="non-small cell lung cancer" FREQUENCY=2 START=162 END=188 LEMMA="NON-SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="non-small cell lung cancer" FREQUENCY=2 START=162 END=188 LEMMA="NON-SMALL CELL LUNG CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="non-squamous cell lung cancer" FREQUENCY=1 START=937 END=966 LEMMA="NON-SQUAMOUS CELL LUNG CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="open-label" FREQUENCY=1 START=1321 END=1331 LEMMA="OPEN-LABEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="preclinical models" FREQUENCY=1 START=1214 END=1232 LEMMA="PRECLINICAL MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="preclinical models of NSCLC" FREQUENCY=1 START=1214 END=1241 LEMMA="NON SMALL CELL LUNG CANCER PRECLINICAL MODEL" LEMMA_FREQUENCY=1 HEAD_TERM="preclinical models" HEAD_LEMMA="PRECLINICAL MODEL"
TERM ID="NYU_TERM_35" STRING="treatment strategy" FREQUENCY=1 START=730 END=748 LEMMA="TREATMENT STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="vinorelbine" FREQUENCY=1 START=539 END=550 LEMMA="VINORELBINE" LEMMA_FREQUENCY=1
